A commercially available preparation ofStaphylococcus aureusbio-products potently inhibits tumour growth in a murine model of mesothelioma

Advances in the biology of malignant pleural mesothelioma

(2011) P.A. Zucali et al.   CANCER TREATMENT REVIEWS

Clostridium perfringens enterotoxin carboxy-terminal fragment is a novel tumor-homing peptide for human ovarian cancer

(2010) Emiliano Cocco et al.   BMC CANCER

Mesothelial cell differentiation into osteoblast- and adipocyte-like cells

(2010) Sally M. Lansley et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Locally Administered TLR7 Agonists Drive Systemic Antitumor Immune Responses That Are Enhanced by Anti-CD40 Immunotherapy

(2009) S. A. Broomfield et al.   JOURNAL OF IMMUNOLOGY

Identification of protein components and quantitative immunoassay for SEC2 in staphylococcin injection

(2009) Ding Ding et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Enhancement of superantigen activity and antitumor response of staphylococcal enterotoxin C2 by site-directed mutagenesis

(2008) Xiaogang Wang et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Staphylococcus aureus enterotoxin C2 mutants: biological activity assay in vitro

(2008) Jing Hui et al.   JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY

Use of lipoteichoic acid-T for pleurodesis in malignant pleural effusion: a phase I toxicity and dose-escalation study

(2008) Najib M Rahman et al.   LANCET ONCOLOGY